HealthFab Secures ₹20 Cr in Series A Funding
Menstrual hygiene-focused direct-to-consumer (D2C) brand HealthFab has successfully raised ₹20 crore (approximately $2.4 million) in its Series A funding round. The round was led by Atomic Capital, with participation from existing investor Mistry Ventures. This funding milestone is significant for HealthFab as it seeks to expand its product offerings and enhance its market presence.
Company Overview
Related Posts
Founded in 2019 by Kiriti Acharjee, Sourav Chakrabarty, and Satyajit Chakraborty, HealthFab has positioned itself as a key player in the period care sector. Known for its innovative products like reusable period underwear and period pain relief creams, the company aims to address a broader spectrum of menstrual wellness. HealthFab’s products are available on major e-commerce platforms such as Amazon, Flipkart, Myntra, and Meesho, as well as quick commerce platforms like Swiggy and Zepto.
The fresh capital will enable HealthFab to expand its product portfolio to include solutions for energy, fatigue, and pain management related to menstrual health. The company also plans to enhance its quick commerce and general trade distribution channels to establish a robust omnichannel presence.
Funding Environment and Competition
HealthFab’s latest funding round brings its total capital raised to nearly $3.7 million. This includes a $1 million pre-Series A round in 2025, with investments from Mistry Ventures, BeyondSeed, and notable angel investors such as Anupam Mittal and Aman Gupta. The brand’s appearance on Shark Tank India further highlights its growing recognition in the Indian startup ecosystem.
The femtech sector in India is witnessing significant growth, with startups like Soothe, PeeSafe, Sanfe, Nua, and Sirona competing for market share. These companies are challenging traditional FMCG giants like Whisper and Stayfree by offering innovative, sustainable, and health-focused solutions. HealthFab’s commitment to sustainability and comprehensive period wellness positions it well within this competitive landscape.
Implications for India’s Startup Ecosystem
HealthFab’s successful funding round underscores the growing investor interest in femtech and menstrual health solutions in India. The company’s shift from a product-centric approach to a broader focus on women’s health and wellness reflects a larger trend in the industry. As HealthFab aims to scale its user base from 500,000 to 5 million over the next three years, it highlights the potential for growth in this sector.
For founders and investors, HealthFab’s journey offers insights into the opportunities within the femtech space. The company’s ability to secure significant funding and expand its product line demonstrates the viability of addressing niche markets with innovative solutions. As the femtech industry continues to evolve, stakeholders should monitor how companies like HealthFab leverage technology and consumer insights to drive growth.
What to Watch Next
For those involved in the Indian startup ecosystem, HealthFab’s next steps will be crucial. The company’s expansion into new product categories and its efforts to build an omnichannel presence could set new benchmarks in the femtech industry. Investors and founders should watch how HealthFab navigates its growth phase and adapts to changing consumer demands, as this could offer valuable lessons for similar ventures in the sector.
